Olugbenga Samuel Michael

Olugbenga Samuel Michael

Auto-generated profile, based on publicly available information

Olugbenga Samuel Michael

University of Missouri

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2019 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
EDElizabeth O. Dangana
Elizabeth O. Dangana
OMOlugbenga S. Michael
Olugbenga S. Michael
TOTolulope E. Omolekulo
Tolulope E. Omolekulo
EAEmmanuel D. Areola
Emmanuel D. Areola
LOLawrence A. Olatunji
Lawrence A. Olatunji
Reduced liver glycogen synthesis might signify increased glucose flux towards fat synthesis and triggers hepatic triglyceride accumulation and dysmetabolism. Adenosine deaminase (ADA) reduces adenosine content which increases glycogenolysis. In the present study, we evaluate the effect of modulating glycogen synthesis and ADA by lithium chloride (LiCl) on nicotine-induced dysmetabolism. Twenty four male Wistar rats (n = 6/group) were allotted into four groups namely; vehicle-treated (po), nicotine-treated (1.0 mg/kg; po), LiCl-treated (5.0 mg/kg; po) and nicotine + LiCl-treated groups. The treatments lasted for 8 weeks. Nicotine exposure resulted in reduced body weight gain, liver weight, visceral adiposity, glycogen content and synthase. Along with increased insulin resistance (IR), fasting plasma glucose, lactate, plasma and hepatic ADA, XO, UA, and triglyceride (TG), total cholesterol (TC), free fatty acid, lipid peroxidation and liver injury markers. However, plasma and hepatic glucose-6-phosphate dehydrogenase-dependent antioxidant defenses were not affected by nicotine exposure. Concurrent treatment with LiCl normalizes all alterations with exception of hepatic TC. This result shows that enhancement of hepatic glycogen synthesis and suppression of ADA/XO/uric acid pathway by lithium can salvage the liver from nicotine-induced TG accumulation.

17 November 2021 in Current Research in Physiology
Verified
Journal Article
Open access
OMOlugbenga S. Michael
Olugbenga S. Michael
OBOlubayode Bamidele
Olubayode Bamidele
POPamela Ogheneovo
Pamela Ogheneovo
TATemitope A. Ariyo
Temitope A. Ariyo
LALawrence D. Adedayo
Lawrence D. Adedayo
FAFunmileyi O. Awobajo
Funmileyi O. Awobajo
Lead acetate associated tissue injury has been linked to altered antioxidant defenses, hyperuricemia and inflammation. We hypothesized that watermelon rind extract, would ameliorate lead acetate-induced hepato-renal injury.

1 September 2020 in Life Sciences
Verified
Journal Article
Closed access
OMO.S. Michael
O.S. Michael
CDC.L. Dibia
C.L. Dibia
OSO.A. Soetan
O.A. Soetan
OAO.A. Adeyanju
O.A. Adeyanju
AOA.L. Oyewole
A.L. Oyewole
ASA.O. Soladoye
A.O. Soladoye

10 January 2020 in Naunyn-Schmiedeberg's Archives of Pharmacology
Verified
Journal Article
Closed access
PDF file
OAOluwaseun Adeyanju
Oluwaseun Adeyanju
TFTimothy O. Falodun
Timothy O. Falodun
OMOlugbenga S. Michael
Olugbenga S. Michael
OSOlaniyi A. Soetan
Olaniyi A. Soetan
AOAboyeji L. Oyewole
Aboyeji L. Oyewole
RARichard D. Agbana
Richard D. Agbana

13 October 2018 in Archives of Physiology and Biochemistry
Verified
Journal Article
Closed access
OAOluwaseun Adeyanju
Oluwaseun Adeyanju
OMO. S. Michael
O. S. Michael
ASA. O. Soladoye
A. O. Soladoye
LOL. A. Olatunji
L. A. Olatunji
Context: Estrogen–progestin combined oral contraceptive (COC) has been connected to mineralocorticoid receptor (MR) activation and adverse cardiometabolic events. We consequently hypothesised that insulin resistance (IR), hyperuricemia, and elevated circulating GSK-3 induced by COC is through activation of MR via mineralocorticoid and glucocorticoid pathways. Methods: Female Wistar rats aged 12 weeks received (po) vehicle and COC (1.0 μg ethinylestradiol plus 5.0 μg levonorgestrel) with or without MR blocker (0.25 mg/kg spironolactone; Spl), daily for eight weeks. Results: Data showed that COC treatment led to increased IR, 1-hour postload glucose level, insulinemia, triglyceride/HDL-cholesterol ratio, total cholesterol/HDL-cholesterol ratio, uric acid, GSK-3, aldosterone, corticosterone values, impaired glucose tolerance and pancreatic β-cell function. However, MR blockade by Spl ameliorated all these alterations except that of aldosterone. Conclusion: The results demonstrate that COC induces IR, hyperuricemia and high GSK-3 levels through activation of MR via glucocorticoid dependent pathway.

3 September 2017 in Archives of Physiology and Biochemistry
Verified
Journal Article
Closed access
OMOlugbenga S. Michael
Olugbenga S. Michael
LOLawrence A. Olatunji
Lawrence A. Olatunji
Context: Cigarette smoking is considered to be a major risk factor for the development of diabetes and cardiovascular disease. Oestrogen-progestin combined oral contraceptive (COC) use has been associated with adverse cardiometabolic events. Objective: We hypothesized that nicotine would ameliorate insulin resistance (IR) that is accompanied by decreased cardiac glycogen synthase kinase-3 (GSK-3) and plasminogen activator inhibitor-1 (PAI-1). Methods: Female Wistar rats received (po) low-(0.1 mg/kg) or high-nicotine (1.0 mg/kg) with or without COC containing 5.0 µg levonorgestrel plus 1.0 µg ethinylestradiol daily for 8 weeks. Results: Data showed that COC treatment or nicotine exposure led to IR, glucose deregulation, atherogenic dyslipidemia, increased corticosterone, aldosterone, cardiac and circulating GSK-3 values and PAI-1. However, these effects with the exception of corticosterone and aldosterone were ameliorated in COC + nicotine-exposed rats. Conclusion: Amelioration of IR induced by COC treatment is accompanied by decreased circulating PAI-1, cardiac PAI-1 and GSK-3 instead of circulating aldosterone and corticosterone.